Keertan Dheda
Impact in
- Infectious Diseases top 0.01%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Epidemiology top 0.1%
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 249
- SARS-CoV-2 and COVID-19 Research 18
- HIV/AIDS Research and Interventions 17
- Epidemiology 143
- Mycobacterium research and diagnosis 62
- Pneumocystis jirovecii pneumonia detection and treatment 50
- Pneumonia and Respiratory Infections 47
- Co-authors
- Alimuddin I. Zumla (41 shared papers)Jim F. Huggett (18 shared papers)Madhukar Pai (33 shared papers)Stephen Andrew Bustin (3 shared papers)G.A.W. Rook (22 shared papers)Grant Theron (56 shared papers)Richard Nellis van Zyl-Smit (40 shared papers)Jonny Peter (48 shared papers)
- Journals
- European Respiratory Journal (29 papers)PLoS ONE (23 papers)American Journal of Respiratory and Critical Care Medicine (21 papers)The Lancet (18 papers)The International Journal of Tuberculosis and Lung Disease (18 papers)
- Partner nations
- South AfricaUnited KingdomUnited States
In The Last Decade
Keertan Dheda
396 papers receiving 31.2k citations
Keertan Dheda's Hit Papers
Peers
Comparison fields: 5 of 198
- Infectious Diseases 20.5k
- Epidemiology 8.9k
- Health 1.4k
- Modeling and Simulation 744
- Surgery 5.5k
Countries citing papers authored by Keertan Dheda
This map shows the geographic impact of Keertan Dheda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keertan Dheda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keertan Dheda more than expected).
Fields of papers citing papers by Keertan Dheda
This network shows the impact of papers produced by Keertan Dheda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keertan Dheda. The network helps show where Keertan Dheda may publish in the future.
Co-authors
The 25 scholars most cited alongside Keertan Dheda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 406 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3621 |
| 2 | Real-time RT-PCR normalisation; strategies and considerations Hit paper breakdown → | 2005 | 1549 |
| 3 | Tuberculosis Hit paper breakdown → | 2016 | 940 |
| 4 | Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant Hit paper breakdown → | 2021 | 905 |
| 5 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 867 |
| 6 | Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis Hit paper breakdown → | 2010 | 845 |
| 7 | Validation of housekeeping genes for normalizing RNA expression in real-time PCR Hit paper breakdown → | 2004 | 843 |
| 8 | Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection Hit paper breakdown → | 2014 | 658 |
| 9 | 2005 | 558 | |
| 10 | The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis Hit paper breakdown → | 2017 | 510 |
| 11 | Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis Hit paper breakdown → | 2018 | 497 |
| 12 | Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant Hit paper breakdown → | 2021 | 472 |
| 13 | Tuberculosis Hit paper breakdown → | 2015 | 465 |
| 14 | Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis Hit paper breakdown → | 2010 | 455 |
| 15 | Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection Hit paper breakdown → | 2018 | 415 |
| 16 | 2013 | 368 | |
| 17 | 2011 | 300 | |
| 18 | 2013 | 282 | |
| 19 | 2017 | 265 | |
| 20 | 2011 | 261 |
About Keertan Dheda
Keertan Dheda is a scholar working on Infectious Diseases, Epidemiology, Surgery, Pulmonary and Respiratory Medicine and Immunology, having authored 406 papers that have together received 32.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (249 papers), Mycobacterium research and diagnosis (62 papers), Infectious Diseases and Tuberculosis (60 papers), Pneumocystis jirovecii pneumonia detection and treatment (50 papers), Pneumonia and Respiratory Infections (47 papers), Diagnosis and treatment of tuberculosis (34 papers), SARS-CoV-2 and COVID-19 Research (18 papers) and HIV/AIDS Research and Interventions (17 papers). The work is most often cited by research in Infectious Diseases (20.5k citations), Epidemiology (8.9k citations), Health (1.4k citations), Modeling and Simulation (744 citations) and Surgery (5.5k citations). Keertan Dheda has collaborated with scholars based in South Africa, United Kingdom and United States. Frequent co-authors include Alimuddin I. Zumla, Jim F. Huggett, Madhukar Pai, Stephen Andrew Bustin, G.A.W. Rook, Grant Theron, Richard Nellis van Zyl-Smit, Jonny Peter, David W. Dowdy and Robin M. Warren. Their work appears in journals such as European Respiratory Journal, PLoS ONE, American Journal of Respiratory and Critical Care Medicine, The Lancet and The International Journal of Tuberculosis and Lung Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.